This year Tariq and Huimin represent the McFarland Labs at Abstract-A-Palooza 2014.

This work highlights a family of Ru(II) complexes that is licensed to Theralase Technologies, Inc. for development as photodynamic compounds for treating bladder cancer.

Metal complexes that, for all practical purposes, do not absorb red light can be activated in the PDT window, owing to highly photosensitizing 3IL excited states.

Marc Hetu participates in an NRC IRAP project with Brian Wilson.